UCC vs. CURE
UCC (ProShares Ultra Consumer Services) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both Leveraged Equities funds - UCC tracks the Dow Jones U.S. Consumer Services Index (200%) while CURE tracks the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, UCC returned 13.99%/yr vs 13.49%/yr for CURE. A 0.52 correlation means they provide meaningful diversification when combined. UCC charges 0.95%/yr vs 1.08%/yr for CURE.
Performance
UCC vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UCC achieves a -8.62% return, which is significantly lower than CURE's -7.96% return. Both investments have delivered pretty close results over the past 10 years, with UCC having a 13.99% annualized return and CURE not far behind at 13.49%.
UCC
- 1D
- 0.57%
- 1M
- -4.37%
- YTD
- -8.62%
- 6M
- -10.29%
- 1Y
- 12.48%
- 3Y*
- 14.37%
- 5Y*
- -0.24%
- 10Y*
- 13.99%
CURE
- 1D
- -0.55%
- 1M
- 13.71%
- YTD
- -7.96%
- 6M
- -6.00%
- 1Y
- 28.51%
- 3Y*
- 3.05%
- 5Y*
- 1.51%
- 10Y*
- 13.49%
UCC vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UCC ProShares Ultra Consumer Services | -8.62% | 2.21% | 44.24% | 61.67% | -57.59% | 20.92% | 46.55% | 53.76% | -4.94% | 42.05% |
CURE Direxion Daily Healthcare Bull 3x Shares | -7.96% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between UCC and CURE is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.37 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.45 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.47 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.52 |
Over the past year, the correlation between UCC and CURE has dropped to 0.31 - well below their long-term average of 0.52, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UCC vs. CURE — Risk / Return Rank
UCC
CURE
UCC vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Consumer Services (UCC) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UCC | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.32 | ||
| Sortino ratioReturn per unit of downside risk | -0.54 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.13 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 0.35 | 0.85 | -0.51 |
| Martin ratioReturn relative to average drawdown | 0.97 | 1.94 | -0.97 |
Loading charts...
Drawdowns
UCC vs. CURE - Drawdown Comparison
The maximum UCC drawdown since its inception was -83.05%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UCC and CURE.
Loading charts...
Drawdown Indicators
| UCC | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.05% | -69.19% | -13.86% |
Max Drawdown (1Y)Largest decline over 1 year | -29.14% | -31.10% | +1.96% |
Max Drawdown (3Y)Largest decline over 3 years | -48.01% | -51.93% | +3.92% |
Max Drawdown (5Y)Largest decline over 5 years | -61.77% | -52.23% | -9.54% |
Max Drawdown (10Y)Largest decline over 10 years | -61.77% | -69.19% | +7.42% |
Current DrawdownCurrent decline from peak | -18.41% | -26.94% | +8.53% |
Average DrawdownAverage peak-to-trough decline | -21.80% | -18.16% | -3.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.45% | 13.71% | -3.26% |
Volatility
UCC vs. CURE - Volatility Comparison
The current volatility for ProShares Ultra Consumer Services (UCC) is 12.41%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 14.30%. This indicates that UCC experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UCC | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.41% | 14.30% | -1.89% |
Volatility (6M)Calculated over the trailing 6-month period | 27.05% | 30.87% | -3.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.41% | 44.32% | -7.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.70% | 43.84% | -0.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.68% | 49.59% | -8.91% |
UCC vs. CURE - Expense Ratio Comparison
UCC has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.
Dividends
UCC vs. CURE - Dividend Comparison
UCC's dividend yield for the trailing twelve months is around 1.18%, more than CURE's 1.16% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.16% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
UCC ProShares Ultra Consumer Services | 1.18% | 1.10% | 0.17% | 0.04% | 0.25% | 0.00% | 0.02% | 0.17% | 0.18% | 0.14% | 0.21% | 0.14% |
Frequently Asked Questions
UCC and CURE have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (14.30%) compared to UCC (12.41%). In terms of maximum drawdown, UCC dropped -83.05% vs CURE's -69.19%.
On 10-year performance, UCC leads with 13.99% vs 13.49% for CURE. On fees, UCC is cheaper at 0.95% per year. On volatility, UCC has been the lower-risk option at 12.41%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, UCC has performed better with a 13.99% return vs 13.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
UCC is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.
UCC has the higher dividend yield at 1.18%, compared with 1.16% for CURE.
UCC tracks Dow Jones U.S. Consumer Services Index (200%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for UCC and 1.08% for CURE.
CURE currently has the higher Sharpe Ratio (0.60 vs 0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UCC and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer